Carl J Caspersen1, G Darlene Thomas2, Gloria L A Beckles2, Kai McKeever Bullard2. 1. Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, Georgia. Electronic address: cjc1@cdc.gov. 2. Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, Georgia.
Abstract
BACKGROUND: Sex-specific prediabetes estimates are not available for older-adult Americans. PURPOSE: To estimate prediabetes prevalence, using nationally representative data, in civilian, non-institutionalized, older U.S. adults. METHODS: Data from 7,995 participants aged ≥50 years from the 1999-2010 National Health and Nutrition Examination Surveys were analyzed in 2013. Prediabetes was defined as hemoglobin A1c=5.7%-6.4% (39-47 mmol/mol [HbA1c5.7]), fasting plasma glucose of 100-125 mg/dL (impaired fasting glucose [IFG]), or both. Crude and age-adjusted prevalences for prediabetes, HbA1c5.7, and IFG by sex and three age groups were calculated, with additional adjustment for sex, age, race/ethnicity, poverty status, education, living alone, and BMI. RESULTS: From 1999 to 2005 and 2006 to 2010, prediabetes increased for adults aged 50-64 years (38.5% [95% CI=35.3, 41.8] to 45.9% [42.3, 49.5], p=0.003) and 65-74 years (41.3% [37.2, 45.5] to 47.9% [44.5, 51.3]; p=0.016), but not significantly for adults aged ≥75 years (45.1% [95% CI=41.1, 49.1] to 48.9% [95% CI=45.2, 52.6]; p>0.05). Prediabetes increased significantly for women in the two youngest age groups, and HbA1c5.7 for both sexes (except men aged ≥75 years), but IFG remained stable for both sexes. Men had higher prevalences than women for prediabetes and IFG among adults aged 50-64 years, and for IFG among adults aged ≥75 years. Across demographic subgroups, adjusted prevalence gains for both sexes were similar and most pronounced for HbA1c5.7, virtually absent for IFG, but greater for women than men for prediabetes. CONCLUSIONS: Given the large, growing prediabetes prevalence and its anticipated burden, older adults, especially women, are likely intervention targets. Published by Elsevier Inc.
BACKGROUND: Sex-specific prediabetes estimates are not available for older-adult Americans. PURPOSE: To estimate prediabetes prevalence, using nationally representative data, in civilian, non-institutionalized, older U.S. adults. METHODS: Data from 7,995 participants aged ≥50 years from the 1999-2010 National Health and Nutrition Examination Surveys were analyzed in 2013. Prediabetes was defined as hemoglobin A1c=5.7%-6.4% (39-47 mmol/mol [HbA1c5.7]), fasting plasma glucose of 100-125 mg/dL (impaired fasting glucose [IFG]), or both. Crude and age-adjusted prevalences for prediabetes, HbA1c5.7, and IFG by sex and three age groups were calculated, with additional adjustment for sex, age, race/ethnicity, poverty status, education, living alone, and BMI. RESULTS: From 1999 to 2005 and 2006 to 2010, prediabetes increased for adults aged 50-64 years (38.5% [95% CI=35.3, 41.8] to 45.9% [42.3, 49.5], p=0.003) and 65-74 years (41.3% [37.2, 45.5] to 47.9% [44.5, 51.3]; p=0.016), but not significantly for adults aged ≥75 years (45.1% [95% CI=41.1, 49.1] to 48.9% [95% CI=45.2, 52.6]; p>0.05). Prediabetes increased significantly for women in the two youngest age groups, and HbA1c5.7 for both sexes (except men aged ≥75 years), but IFG remained stable for both sexes. Men had higher prevalences than women for prediabetes and IFG among adults aged 50-64 years, and for IFG among adults aged ≥75 years. Across demographic subgroups, adjusted prevalence gains for both sexes were similar and most pronounced for HbA1c5.7, virtually absent for IFG, but greater for women than men for prediabetes. CONCLUSIONS: Given the large, growing prediabetes prevalence and its anticipated burden, older adults, especially women, are likely intervention targets. Published by Elsevier Inc.
Authors: Cherie James; Kai McKeever Bullard; Deborah B Rolka; Linda S Geiss; Desmond E Williams; Catherine C Cowie; Ann Albright; Edward W Gregg Journal: Diabetes Care Date: 2011-02 Impact factor: 19.112
Authors: Catherine C Cowie; Keith F Rust; Earl S Ford; Mark S Eberhardt; Danita D Byrd-Holt; Chaoyang Li; Desmond E Williams; Edward W Gregg; Kathleen E Bainbridge; Sharon H Saydah; Linda S Geiss Journal: Diabetes Care Date: 2008-11-18 Impact factor: 17.152
Authors: Pearl G Lee; Christine T Cigolle; Jinkyung Ha; Lillian Min; Susan L Murphy; Caroline S Blaum; William H Herman Journal: Diabetes Care Date: 2013-06-11 Impact factor: 19.112
Authors: Stephanie T Chung; Amber B Courville; Anthony U Onuzuruike; Mirella Galvan-De La Cruz; Lilian S Mabundo; Christopher W DuBose; Kannan Kasturi; Hongyi Cai; Ahmed M Gharib; Peter J Walter; H Martin Garraffo; Shaji Chacko; Morey W Haymond; Anne E Sumner Journal: JCI Insight Date: 2018-09-20
Authors: Octavian C Ioachimescu; Jeremy Anthony; Tina Constantin; Mary-Margaret Ciavatta; Kandace McCarver; Mary Ellen Sweeney Journal: J Clin Sleep Med Date: 2017-03-15 Impact factor: 4.062